| Merck (Schweiz) AG - Rebif 8.8 und 22 RebiDose, Injektionslösung im Fertigpen | | 62067 | | 01 | | Rebif 8.8 und 22 RebiDose | | Injektionslösung im Fertigpen | | L03AB07 | | Interferon Beta-1a | | 13.02.2012 | | |
| | Composition | | I) 8.8 mcg/0.2 ml: interferonum beta-1a ADNr 8.8 µg corresp. 2.4 Mio U.I., alcohol benzylicus 1.0 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml corresp. natrium 0.01 mg.
II) 22 mcg / 0.5 ml: interferonum beta-1a ADNr 22 µg corresp. 6 Mio U.I., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg. | | Packungsbestandteile | | I | | | Injektionslösung im Fertigpen | | | | | | | | Active Agent | Dose |
|---|
| Interferonum Beta-1a Adnr | 8.8µg / 0.2ml |
| | BAG: Active Agent | Dose |
|---|
| Interferonum Beta-1a Adnr | 22 mcg |
| | | | Inactive agents | Dose |
|---|
| Acetic Acid | | | Alcohol Benzylicus | 1mg / 0.2ml | | Mannitol | | | Methionine | | | Sodium Acetate Trihydrate | | | Sodium Hydroxide | | | Poloxamer | 188 |
| |
| II | | | Injektionslösung im Fertigpen | | | | | | | | Active Agent | Dose |
|---|
| Interferonum Beta-1a Adnr | 22µg / 0.5ml |
| | BAG: Active Agent | Dose |
|---|
| Interferonum Beta-1a Adnr | 22 mcg |
| | | | Inactive agents | Dose |
|---|
| Acetic Acid | | | Alcohol Benzylicus | 2.5mg / 0.5ml | | Mannitol | | | Methionine | | | Sodium Acetate Trihydrate | | | Sodium Hydroxide | | | Poloxamer | 188 |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 6 syringe(s) | 599.44 | 668.35 | B | SL | Yes |
|
|
